Inflammatory Bowel Disease News

Oral vancomycin therapy resulted in clinical response in nearly half of patients with inflammatory bowel disease associated with primary sclerosing cholangitis, according to a study published in Therapeutic Advances in Gastroenterology.

SAN FRANCISCO — Most patients with moderately to severely active Crohn’s disease who achieved endoscopic response and remission after 52 weeks of Omvoh therapy maintained those results through 104 weeks, according to VIVID-2 study results.

SAN FRANCISCO — Although Stelara and Entyvio demonstrated similar cardiovascular safety profiles among older patients with inflammatory bowel disease, Stelara was associated with reduced all-cause mortality risk over 3 years, data showed.

SAN FRANCISCO — Patients with inflammatory bowel disease remain at higher risk for mental health disorders, but training support staff to recognize the symptoms could be key to preventing further traumatization, noted a presenter here.

SAN FRANCISCO — Despite advances in treatment for inflammatory bowel disease, more than 55% of patients report medication delays, mostly due to insurance challenges, and many make financial trade-offs to afford care, survey results showed.

SAN FRANCISCO — Patient activation, earned trust and health literacy at patient, provider and health system levels are critical to overcoming health disparities among pediatric patients with inflammatory bowel disease, noted a presenter.

SAN FRANCISCO — IBD Aware, a wearable medical device in development for patients with inflammatory bowel disease, aims to improve disease monitoring by continuously measuring biomarkers in sweat, according to the creators of the device.

Women with inflammatory bowel disease who delivered a twin gestation pregnancy had higher rates of preterm delivery and infants born small for gestational age or with low birthweight compared with healthy controls, according to research.

Exposure to various air pollutants, such as PM2.5 and nitrogen oxides, increases the risk for several autoimmune diseases, including psoriasis, lupus and rheumatoid arthritis, according to data published in Scientific Reports.